Sourbha Dani to Cardiovascular Agents
This is a "connection" page, showing publications Sourbha Dani has written about Cardiovascular Agents.
Connection Strength
1.008
-
Dani SS, Majithia A, Ssemaganda H, Robbins S, Bertges DJ, Eldrup-Jorgensen J, Sedrakyan A, Levy M, Siami FS, Joynt Maddox KE, Matheny M, Secemsky E, Resnic F. Real-World Safety Analysis of Paclitaxel Devices Used for the Treatment of Peripheral Artery Disease. J Vasc Interv Radiol. 2023 07; 34(7):1157-1165.e8.
Score: 0.778
-
Abraham S, Nohria A, Neilan TG, Asnani A, Saji AM, Shah J, Lech T, Grossman J, Abraham GM, McQuillen DP, Martin DT, Sax PE, Dani SS, Ganatra S. Cardiovascular Drug Interactions With?Nirmatrelvir/Ritonavir in Patients?With COVID-19: JACC?Review Topic of the Week. J Am Coll Cardiol. 2022 11 15; 80(20):1912-1924.
Score: 0.188
-
Bang V, Ganatra S, Shah SP, Dani SS, Neilan TG, Thavendiranathan P, Resnic FS, Piemonte TC, Barac A, Patel R, Sharma A, Parikh R, Chaudhry GM, Vesely M, Hayek SS, Leja M, Venesy D, Patten R, Lenihan D, Nohria A, Cooper LT. Management of Patients With Giant Cell Myocarditis: JACC Review Topic of the Week. J Am Coll Cardiol. 2021 03 02; 77(8):1122-1134.
Score: 0.042